In 51 gynaecological patients the effect of an injectable salicylate (lysine acetylsalicylate 1.8 g) on postoperative pain was compared with that of morphine hydrochloride 10 mg. Both drugs were given i.m. No significant difference was found in the speed of action and degree of alleviation of pain. Nausea and vomiting were less frequent in the lysine acetylsalicylate group. This group showed a decrease in capillary blood Pco,, 1 hour after injection, which was significantly greater than that in the morphine group. In the morphine group the decrease in PcOa correlated with a small increase in Po 2 , but in the lysine acetylsalicylate group this correlation did not exist.
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Control of postoperative pain by simple non-narcotic analgesics has so far been possible only by the oral route. Since the oral administration of a drug is often impossible immediately after operation, the use of morphine-like drugs, by injection, has become common practice. One possible disadvantage of the use of this type of drug is respiratory depression. Recently several authors have reported good analgesia following the injection of lysine acetylsalicylate (Aron, Delbarre and Jankowski et al., 1970; Frere et al., 1971; Gautier-Benoit, 1970) .
Lysine acetylsalicylate is a soluble salt of acetylsalicylic acid, and thus has pharmacological actions similar to those of acetylsalicylic acid. However, none of the above-mentioned trials was properly controlled, and we have conducted a double-blind study comparing lysine acetylsalicylate with morphine hydrochloride in the treatment of pain after gynaecological operations.
PATIENTS AND METHODS
Patients, mostly middle-aged, in good physical condition, undergoing major gynaecological surgery were screened in advance for their tolerance to acetylsalicylic acid by determination of their bleeding time 12 hours after the administration of lysine acetylsalicylate 1.8 g orally (the equivalent of acetylsalicylic acid 1.0 g) (Gast, 1964; Quick, 1966) . A bleeding time of 6 min was set as the limit for inclusion in our study. Patients receiving anticoagulant therapy were excluded (O'Reilly and Aggeler, 1970) . Tolerance to acetylsalicylic acid was determined in 106 patients of whom only 2 were eliminated because of a bleeding time longer than 6 min. A moderately increased bleeding time (4-6 min) was observed in 29 patients. The remaining 75 patients had a normal bleeding time equal to or less than 4 min.
Of all the patients screened in advance only 59 were included in the trial; the other 45 patients were not seen by us, because they were not operated upon while the trial was being conducted. Of these 59 patients 6 required no analgesic and 2 were eliminated because the correct protocol had not been followed.
Drug regimen.
Analgesics were given only when requested by the patient. They received randomly morphine hydrochloride 10 mg (M group) i.m. or lysine acetylsalicylate 1.8 g (LA group) i.m. If no improvement had occurred within 1 hour of the first injection, the other drug was given.
The effect of the drug was studied for 6 hours after the last injection. If after a second injection the effect was not satisfactory, pain relief was obtained by other means.
The trial was carried out double-blind. Both drugs were delivered by the hospital pharmacy in one package. For each patient the drugs were marked "A" and "B", in a random order.
Pain scoring.
Patients were asked about the intensity of their pain, which was scored as follows: 0=no pain; 1 = slight pain; 2=moderate pain; 3=unbearable pain.
BRITISH JOURNAL OF ANAESTHESIA They were also asked whether or not they felt any change in the intensity of pain since the previous time of scoring. This was scored as follows: 1 = improved; 0 = unchanged; -1 = aggravated. Pain scoring was assessed before injection and at 30 min, 1, 2, 3, 4, 5 and 6 hours after injection. Nausea and vomiting were noted only when reported spontaneously.
Blood-gas values.
Pco 2 and Po 2 were determined in free-flowing capillary blood before and 1 hour after injection.
RESULTS
Twenty-six patients received M as the first drug and 25 received LA. There was no apparent difference between the two groups as to type of operation or type of anaesthesia (table I), or in pain intensity before injection (table II) . The number of patients who required the second drug 6 hours or less after the first was similar in both groups (12 in the M group, 11 in the LA group). The time after the first injection at which the second injection was asked for varied from lj to 6 hours, so the data are complete only for the first hour.
As the number of patients with unbearable pain was small, they were taken together with those with The change in subjective pain intensity scores was not significantly different in the two groups after 30 min (table Va,b), nor were the summated alleviation scores at 30 min and 1 hour after injection (table VIa,b). The only side effects noted were nausea and vomiting, which occurred in 9 of the patients in the M group, and in 3 of the patients in the LA group. This difference was not statistically significant (P=0.10). There is no such difference in the increase in Po,. In the M group a significant correlation between the decrease in Pco 2 and the increase in Po 2 was shown (r=0.53); in the LA group the correlation was not significant (r=0.02).
DISCUSSION
Our results suggest that 1.8 g lysine acetylsalicylate given by injection is at least as good as 10 mg morphine hydrochloride in the treatment of postoperative pain, and that its onset of action may be even quicker. Nausea and vomiting are less after lysine acetylsalicylate than after morphine hydrochloride, but this difference is not significant. It is interesting to note that the capillary Pco, decreases following both drugs. This might be the result of improved analgesia, but in this small number of patients we could not find any relation between pain relief and the reduction in Pco,. The difference between morphine hydrochloride and lysine acetylsalicylate could be due to respiratory depression by morphine hydrochloride.
